Dr. Michael Doney
Executive Medical Director
Dr. Michael Doney
Executive Medical Director
Dr. Michael Doney
Executive Medical Director



Dr. Doney is the Executive Medical Director of Biograph and an early proponent of the application of multi-omics to precision preventive care.
After earning his medical degree from the University of Cincinnati College of Medicine in 1999 and completing his emergency medicine residency at the University of California San Diego Medical Center, Dr. Doney has leveraged his extensive medical background to delve into the realms of personalized and precision medicine. Prior to Biograph he served as the Director of Medical Affairs at both Human Longevity and Color where he advised the commercial team on structuring the clinical programming.
Dr. Doney's contributions to longevity research include the application of advanced technologies such as whole-genome sequencing and comprehensive metabolomics to tailor health strategies that aim to slow aging processes. His expertise lies in integrating these high-tech tools with traditional medical practices to enhance patient outcomes, particularly focusing on the development of digital platforms and decision support tools that engage both patients and healthcare providers in proactive health management.
His research and clinical practice are influenced by his deep understanding of the biological underpinnings of aging, making him a key player in translating complex scientific insights into practical, actionable health strategies. Through his work, Dr. Doney champions a future where longevity is not just about adding years to life but enhancing the quality of those years.
Dr. Doney is the Executive Medical Director of Biograph and an early proponent of the application of multi-omics to precision preventive care.
After earning his medical degree from the University of Cincinnati College of Medicine in 1999 and completing his emergency medicine residency at the University of California San Diego Medical Center, Dr. Doney has leveraged his extensive medical background to delve into the realms of personalized and precision medicine. Prior to Biograph he served as the Director of Medical Affairs at both Human Longevity and Color where he advised the commercial team on structuring the clinical programming.
Dr. Doney's contributions to longevity research include the application of advanced technologies such as whole-genome sequencing and comprehensive metabolomics to tailor health strategies that aim to slow aging processes. His expertise lies in integrating these high-tech tools with traditional medical practices to enhance patient outcomes, particularly focusing on the development of digital platforms and decision support tools that engage both patients and healthcare providers in proactive health management.
His research and clinical practice are influenced by his deep understanding of the biological underpinnings of aging, making him a key player in translating complex scientific insights into practical, actionable health strategies. Through his work, Dr. Doney champions a future where longevity is not just about adding years to life but enhancing the quality of those years.
Dr. Doney is the Executive Medical Director of Biograph and an early proponent of the application of multi-omics to precision preventive care.
After earning his medical degree from the University of Cincinnati College of Medicine in 1999 and completing his emergency medicine residency at the University of California San Diego Medical Center, Dr. Doney has leveraged his extensive medical background to delve into the realms of personalized and precision medicine. Prior to Biograph he served as the Director of Medical Affairs at both Human Longevity and Color where he advised the commercial team on structuring the clinical programming.
Dr. Doney's contributions to longevity research include the application of advanced technologies such as whole-genome sequencing and comprehensive metabolomics to tailor health strategies that aim to slow aging processes. His expertise lies in integrating these high-tech tools with traditional medical practices to enhance patient outcomes, particularly focusing on the development of digital platforms and decision support tools that engage both patients and healthcare providers in proactive health management.
His research and clinical practice are influenced by his deep understanding of the biological underpinnings of aging, making him a key player in translating complex scientific insights into practical, actionable health strategies. Through his work, Dr. Doney champions a future where longevity is not just about adding years to life but enhancing the quality of those years.